Global Muscle Hypotonia Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 123.40 Million |
 Market Size (Forecast Year) |
USD 240.52 Million |
 CAGR |
% |
| Major Markets Players |
全球肌张力减退市场，按类型（获得性肌张力减退和先天性肌张力减退）、治疗（物理治疗、职业治疗、言语和语言治疗、药物）、诊断（体检、肌肉活检）、给药途径（口服、注射和其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、零售药房、在线药房和其他）划分——行业趋势和预测到 2030 年。
肌肉张力减退市场分析及规模
肌张力低下通常出生时就存在，通常在婴儿早期就被诊断出来。婴儿肌张力低下的原因有多种。许多肌张力低下病例是先天性的。在先天性肌张力低下中，中枢病变占大多数。这些通常包括缺氧缺血性脑病或遗传异常。大约 60%-80% 的病例会出现中枢肌张力低下。很少情况下，肌张力低下是由肉毒杆菌感染或接触毒物或毒素引起的。不过，肌张力低下通常会在康复后消失。
Data Bridge Market Research 分析了 2023-2030 年预测期内肌张力减退市场的增长率。在上述预测期内，肌张力减退市场的预期复合年增长率趋于 8.7% 左右。2022 年市场价值为 1.234 亿美元，到 2030 年将增长至 2.4052 亿美元。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
肌肉张力减退市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（后天性肌张力低下和先天性肌张力低下）、治疗（物理治疗、职业治疗、言语和语言治疗、药物）、诊断（体检、肌肉活检）、给药途径（口服、注射和其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、零售药房、网上药房和其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
LivaNova PLC (U.K.), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc. (U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Hypotonia also known as floppy baby syndrome that, means decreased muscle tone. It is mainly witnessed in children. Low-toned muscles contract very slowly in response to a stimulus, and as a result, contraction cannot be maintained for a longer period of time than normal muscle. Damage to the brain, spinal cord, nerves, or muscles can cause hypotonia. These damages can be the consequences of genetic, trauma, environmental factors, muscle, or central nervous system disorders.
Global Muscle Hypotonia Market Dynamics
Drivers
- Rising Prevalence of Musculoskeletal Issues
The growing prevalence of musculoskeletal problems and increasing customer awareness of their treatment and management enhance the market's growth. Structurally distinct medications are the recent technologically improved muscle hypotonias which are used to calm muscle spasms, discomfort, and hyperreflexia. This boosts the growth of the market.
- Growing Prevalence of Hypotonia
Central hypotonia is witnessed in up to 60%-80% of cases. Spinal muscular atrophy has an occurrence of 1 in 6,000 to 1 in 10,000 live births. In the USA, California, Pennsylvania, and Utah have a high prevalence of infant botulism, with around 50% of cases in California. This led to the growth of the market.
Opportunities
- Growing Prevalence of Lower Back Pain
As per the records of the WHO, the non-specific burden of lower back pain has increased significantly worldwide, which is expected at 60–70% in industrialized countries, whereas the one-year occurrence rate increased rate 15–45%, adult prevalence 5% per annum and mostly prevalence of lower back pain has seen in people above 35 years. Thus, this factor demands more drugs and, as a result, increases the market growth.
- Increased Demand of Varied Treatment Options
There are numerous treatment options that lead to the growth of the market. Rehabilitation, nutritional, and respiratory support are some of the major treatment options. Specific treatment can be provided in specific cases such as Pompe disease, wherein early enzyme replacement therapy can considerably improve the outcome. Thus, this leads to market expansion.
Restraints/Challenges
- Adverse Side-Effects of Muscle Hypotonias
There are severe side effects related to the drugs of muscle hypotonias, such as dizziness, dry mouth, tiredness, and depression which restrict the market growth.
- High Investment and Strict Regulatory Norms
肌张力减退市场的增长受到多种因素的限制，例如严格的监管要求和与肌张力减退相关的风险。作为一项复杂的过程，开发制药和生物制药的原材料的使用、分离和开发需要专业和合格的人员。因此，所有这些因素都限制了肌张力减退药物需求的增长。
本肌张力减退市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关肌张力减退市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球肌肉张力减退症市场范围
肌张力减退市场根据类型、治疗、诊断、给药途径、最终用户、分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 获得性肌张力低下
- 先天性肌张力低下
治疗
- 理疗
- 职业治疗
- 言语和语言治疗
- 药物
诊断
- 体格检查
- 肌肉活检
给药途径
- 口服
- 注射剂
- 其他的
最终用户
- 医院
- 家庭护理
- 专科诊所
- 其他的
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
肌张力低下药物市场区域分析/见解
对肌张力低下市场进行了分析，并按类型、治疗、诊断、给药途径、最终用户、分销渠道提供了市场规模洞察和趋势。
肌张力低下市场报告涉及的主要国家 包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于患者人数不断增长、医疗支出高昂、技术发达以及政府对该地区研发的支持增加，北美被认为在预测期内拥有最高的利润增长。
由于医疗技术的快速发展、庞大的患者群体和高昂的医疗费用，亚太地区在市场上占据主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球肌张力低下市场份额分析
肌张力减退市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对肌张力减退市场的关注有关。
肌张力低下市场的主要参与者包括：
- LivaNova PLC（英国）
- EnteroMedics Inc.（美国）
- ElectroCore Medical LLC（美国）
- 波士顿科学公司 (美国)
- Cyberonics, Inc.（美国）
- NeuroMetrix, Inc.（美国）
- ImThera Medical（美国）
- Inspire Medical Systems, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
